Nul

Nul, an innovative alcohol reduction startup, has successfully secured $1 million in a seed funding round. This investment, led by dmg ventures and BYVP, is set to propel Nul's commercial launch across the UK and pave the way for future international expansion, including into the US market.

Summary of transaction details:

• Value: £800,000 (approximate)
• Sector: HealthTech, Digital Wellbeing
• Advisor: Not specified
• Key Entities: Nul (Target), dmg ventures, BYVP (Lead Investors)
• Location: London, UK

Note: This funding round underscores growing investor confidence in digital health platforms that address significant societal challenges through accessible, evidence-based solutions. Nul's unique combination of clinical care, prescription medication, and behavioral support positions it strongly within the evolving telehealth landscape.